| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 3.74e-11 | 5 | 166 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 2.23e-10 | 6 | 166 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.52e-07 | 16 | 166 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAB39 AMY1A AMY1B AMY1C AMY2A AMY2B PLCD4 ACTN4 ACTN1 CUBN IDS DYSF DNAH7 TGM2 HMCN1 SPOCK3 TLL1 PCDH15 DLK2 VWA2 | 4.33e-06 | 749 | 166 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 4.57e-05 | 9 | 166 | 3 | GO:0043878 | |
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 6.49e-05 | 10 | 166 | 3 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 6.49e-05 | 10 | 166 | 3 | GO:0070740 | |
| GeneOntologyMolecularFunction | 3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity | 6.87e-05 | 2 | 166 | 2 | GO:0004119 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.52e-04 | 13 | 166 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.94e-04 | 190 | 166 | 8 | GO:0004252 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA ligase activity | 2.05e-04 | 3 | 166 | 2 | GO:0090433 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 2.39e-04 | 15 | 166 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 3.47e-04 | 207 | 166 | 8 | GO:0008236 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 3.52e-04 | 17 | 166 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 4.07e-04 | 212 | 166 | 8 | GO:0017171 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 4.08e-04 | 4 | 166 | 2 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 4.08e-04 | 4 | 166 | 2 | GO:0047685 | |
| GeneOntologyMolecularFunction | cupric ion binding | 6.76e-04 | 5 | 166 | 2 | GO:1903135 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 6.76e-04 | 5 | 166 | 2 | GO:0047894 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 8.84e-04 | 23 | 166 | 3 | GO:0016881 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.30e-03 | 97 | 166 | 5 | GO:0008081 | |
| GeneOntologyMolecularFunction | 3-chloroallyl aldehyde dehydrogenase activity | 1.40e-03 | 7 | 166 | 2 | GO:0004028 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 1.40e-03 | 7 | 166 | 2 | GO:0050294 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.70e-03 | 103 | 166 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCF3 ATG7 ABCA13 SMC1A KIF12 MCM5 ATP13A2 DNAH7 ACSL3 ACSL4 DNAH12 NAV3 KIF5A | 1.91e-03 | 614 | 166 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.10e-03 | 65 | 166 | 4 | GO:0004714 | |
| GeneOntologyBiologicalProcess | muscle cell development | COL6A1 XIRP1 ANK2 MYOM1 ATG7 OBSCN ACTN4 ACTN1 DYSF ALPK3 PRKG1 | 7.93e-06 | 259 | 165 | 11 | GO:0055001 |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 8.66e-06 | 17 | 165 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.11e-05 | 18 | 165 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 3.11e-05 | 23 | 165 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1D FLNB XIRP1 THSD7A ANK2 MYOM1 OBSCN ACTN4 ACTN1 TF PTK7 LLGL1 HMCN1 GAS2L2 SCN3A SCN7A CLEC2D PCDH15 ARHGAP28 PRKG1 | 4.27e-05 | 912 | 165 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | protein localization to M-band | 6.36e-05 | 2 | 165 | 2 | GO:0036309 | |
| GeneOntologyCellularComponent | Z disc | 2.08e-04 | 151 | 166 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | 3.44e-04 | 273 | 166 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | I band | 3.70e-04 | 166 | 166 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 3.72e-04 | 4 | 166 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | laminin-5 complex | 3.72e-04 | 4 | 166 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | basement membrane | 4.33e-04 | 122 | 166 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.33e-04 | 290 | 166 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network membrane | 6.17e-04 | 5 | 166 | 2 | GO:0098826 | |
| GeneOntologyCellularComponent | sarcomere | 8.68e-04 | 249 | 166 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | secretory granule lumen | 1.19e-03 | 325 | 166 | 9 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 1.33e-03 | 330 | 166 | 9 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 1.38e-03 | 332 | 166 | 9 | GO:0031983 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.65e-03 | 107 | 166 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.65e-03 | 107 | 166 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | M band | 1.88e-03 | 31 | 166 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.99e-03 | 67 | 166 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | intercalated disc | 2.10e-03 | 68 | 166 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | extracellular matrix | COL6A1 VWF LAMA3 LAMA5 CPZ TF TGM2 HMCN1 SPOCK3 ADAMTS17 PLG MUC2 VWA2 | 2.28e-03 | 656 | 166 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL6A1 VWF LAMA3 LAMA5 CPZ TF TGM2 HMCN1 SPOCK3 ADAMTS17 PLG MUC2 VWA2 | 2.34e-03 | 658 | 166 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | actomyosin | 2.44e-03 | 117 | 166 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.53e-03 | 118 | 166 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | supramolecular fiber | CAB39 CACNA1D COL6A1 FLNB ANK2 MYOM1 OBSCN KIF12 ACTN4 ACTN1 DYSF DNAH7 DNAH12 GAS2L2 TTLL11 TTLL4 NAV3 KIF5A LZTS2 | 2.64e-03 | 1179 | 166 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | inner dynein arm | 2.71e-03 | 10 | 166 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | laminin complex | 2.71e-03 | 10 | 166 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | supramolecular polymer | CAB39 CACNA1D COL6A1 FLNB ANK2 MYOM1 OBSCN KIF12 ACTN4 ACTN1 DYSF DNAH7 DNAH12 GAS2L2 TTLL11 TTLL4 NAV3 KIF5A LZTS2 | 2.85e-03 | 1187 | 166 | 19 | GO:0099081 |
| Domain | Alpha_amylase | 5.32e-09 | 4 | 161 | 4 | IPR006046 | |
| Domain | Aamy_C | 5.32e-09 | 4 | 161 | 4 | SM00632 | |
| Domain | Alpha-amylase_C | 2.64e-08 | 5 | 161 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 2.64e-08 | 5 | 161 | 4 | IPR006048 | |
| Domain | Glyco_hydro_13_cat_dom | 1.82e-07 | 7 | 161 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 1.82e-07 | 7 | 161 | 4 | PF00128 | |
| Domain | Aamy | 1.82e-07 | 7 | 161 | 4 | SM00642 | |
| Domain | A-amylase_C | 6.29e-07 | 3 | 161 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 6.74e-06 | 15 | 161 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 1.23e-05 | 6 | 161 | 3 | IPR015902 | |
| Domain | C8 | 1.31e-04 | 12 | 161 | 3 | PF08742 | |
| Domain | TIL | 1.31e-04 | 12 | 161 | 3 | PF01826 | |
| Domain | TTL | 1.69e-04 | 13 | 161 | 3 | PS51221 | |
| Domain | TTL/TTLL_fam | 1.69e-04 | 13 | 161 | 3 | IPR004344 | |
| Domain | Unchr_dom_Cys-rich | 1.69e-04 | 13 | 161 | 3 | IPR014853 | |
| Domain | C8 | 1.69e-04 | 13 | 161 | 3 | SM00832 | |
| Domain | TTL | 1.69e-04 | 13 | 161 | 3 | PF03133 | |
| Domain | TIL_dom | 2.13e-04 | 14 | 161 | 3 | IPR002919 | |
| Domain | - | 2.13e-04 | 14 | 161 | 3 | 2.60.40.1180 | |
| Domain | CH | 2.43e-04 | 65 | 161 | 5 | SM00033 | |
| Domain | Glyco_hydro_catalytic_dom | 3.12e-04 | 38 | 161 | 4 | IPR013781 | |
| Domain | VWF_type-D | 3.24e-04 | 16 | 161 | 3 | IPR001846 | |
| Domain | VWFD | 3.24e-04 | 16 | 161 | 3 | PS51233 | |
| Domain | VWD | 3.24e-04 | 16 | 161 | 3 | SM00216 | |
| Domain | Ald_DH_CS_GLU | 3.24e-04 | 16 | 161 | 3 | IPR029510 | |
| Domain | VWD | 3.24e-04 | 16 | 161 | 3 | PF00094 | |
| Domain | CH | 3.45e-04 | 70 | 161 | 5 | PF00307 | |
| Domain | - | 3.68e-04 | 71 | 161 | 5 | 1.10.418.10 | |
| Domain | Ald_DH_CS_CYS | 3.91e-04 | 17 | 161 | 3 | IPR016160 | |
| Domain | CH | 4.19e-04 | 73 | 161 | 5 | PS50021 | |
| Domain | Aldehyde_DH_NAD(P) | 4.38e-04 | 4 | 161 | 2 | IPR012394 | |
| Domain | Peptidase_S1A | 4.42e-04 | 113 | 161 | 6 | IPR001314 | |
| Domain | CTCK_1 | 4.66e-04 | 18 | 161 | 3 | PS01185 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 4.66e-04 | 18 | 161 | 3 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 4.66e-04 | 18 | 161 | 3 | PS00687 | |
| Domain | CH-domain | 4.75e-04 | 75 | 161 | 5 | IPR001715 | |
| Domain | TRYPSIN_DOM | 4.85e-04 | 115 | 161 | 6 | PS50240 | |
| Domain | EGF_2 | 4.98e-04 | 265 | 161 | 9 | PS01186 | |
| Domain | Tryp_SPc | 5.32e-04 | 117 | 161 | 6 | SM00020 | |
| Domain | - | 5.50e-04 | 19 | 161 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 5.50e-04 | 19 | 161 | 3 | PF00171 | |
| Domain | VWC_out | 5.50e-04 | 19 | 161 | 3 | SM00215 | |
| Domain | Ald_DH_C | 5.50e-04 | 19 | 161 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 5.50e-04 | 19 | 161 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 5.50e-04 | 19 | 161 | 3 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 5.50e-04 | 19 | 161 | 3 | IPR015590 | |
| Domain | - | 5.50e-04 | 19 | 161 | 3 | 3.40.309.10 | |
| Domain | Trypsin_dom | 6.35e-04 | 121 | 161 | 6 | IPR001254 | |
| Domain | Trypsin | 6.35e-04 | 121 | 161 | 6 | PF00089 | |
| Domain | Peptidase_S1_PA | 6.92e-04 | 123 | 161 | 6 | IPR009003 | |
| Domain | Laminin_domII | 7.26e-04 | 5 | 161 | 2 | IPR010307 | |
| Domain | Laminin_aI | 7.26e-04 | 5 | 161 | 2 | IPR009254 | |
| Domain | Laminin_I | 7.26e-04 | 5 | 161 | 2 | PF06008 | |
| Domain | Laminin_II | 7.26e-04 | 5 | 161 | 2 | PF06009 | |
| Domain | SEA | 8.58e-04 | 22 | 161 | 3 | PF01390 | |
| Domain | CT | 8.58e-04 | 22 | 161 | 3 | SM00041 | |
| Domain | ACTININ_2 | 9.81e-04 | 23 | 161 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.81e-04 | 23 | 161 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.81e-04 | 23 | 161 | 3 | IPR001589 | |
| Domain | SEA | 9.81e-04 | 23 | 161 | 3 | PS50024 | |
| Domain | SEA_dom | 9.81e-04 | 23 | 161 | 3 | IPR000082 | |
| Domain | EFhand_Ca_insen | 1.08e-03 | 6 | 161 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.08e-03 | 6 | 161 | 2 | IPR014837 | |
| Domain | WxxW_domain | 1.08e-03 | 6 | 161 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.08e-03 | 6 | 161 | 2 | PF13330 | |
| Domain | TRYPSIN_SER | 1.09e-03 | 90 | 161 | 5 | IPR033116 | |
| Domain | Glycoside_hydrolase_SF | 1.12e-03 | 53 | 161 | 4 | IPR017853 | |
| Domain | - | 1.26e-03 | 25 | 161 | 3 | 3.20.20.190 | |
| Domain | Cys_knot_C | 1.26e-03 | 25 | 161 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.26e-03 | 25 | 161 | 3 | PS01225 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.26e-03 | 25 | 161 | 3 | IPR017946 | |
| Domain | Ig_I-set | 1.32e-03 | 190 | 161 | 7 | IPR013098 | |
| Domain | I-set | 1.32e-03 | 190 | 161 | 7 | PF07679 | |
| Domain | EGF-like_CS | 1.95e-03 | 261 | 161 | 8 | IPR013032 | |
| Domain | TRYPSIN_HIS | 1.99e-03 | 103 | 161 | 5 | IPR018114 | |
| Domain | LAMININ_IVA | 2.00e-03 | 8 | 161 | 2 | PS51115 | |
| Domain | Laminin_B | 2.00e-03 | 8 | 161 | 2 | PF00052 | |
| Domain | LamB | 2.00e-03 | 8 | 161 | 2 | SM00281 | |
| Domain | Laminin_IV | 2.00e-03 | 8 | 161 | 2 | IPR000034 | |
| Domain | TSP_1 | 2.13e-03 | 63 | 161 | 4 | PF00090 | |
| Domain | TRYPSIN_SER | 2.25e-03 | 106 | 161 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.35e-03 | 107 | 161 | 5 | PS00134 | |
| Domain | Growth_fac_rcpt_ | 2.35e-03 | 156 | 161 | 6 | IPR009030 | |
| Domain | TSP1 | 2.39e-03 | 65 | 161 | 4 | SM00209 | |
| Domain | TSP1_rpt | 2.39e-03 | 65 | 161 | 4 | IPR000884 | |
| Domain | TSP1 | 2.39e-03 | 65 | 161 | 4 | PS50092 | |
| Domain | GPS | 3.09e-03 | 34 | 161 | 3 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 3.09e-03 | 34 | 161 | 3 | IPR017983 | |
| Domain | Na_channel_asu | 3.18e-03 | 10 | 161 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 3.18e-03 | 10 | 161 | 2 | IPR010526 | |
| Domain | GBP_C | 3.18e-03 | 10 | 161 | 2 | PF02841 | |
| Domain | Na_trans_assoc | 3.18e-03 | 10 | 161 | 2 | PF06512 | |
| Domain | - | 3.36e-03 | 35 | 161 | 3 | 3.20.20.80 | |
| Domain | GPS | 3.36e-03 | 35 | 161 | 3 | PF01825 | |
| Domain | EF-hand-dom_pair | 3.50e-03 | 287 | 161 | 8 | IPR011992 | |
| Domain | GPS | 3.64e-03 | 36 | 161 | 3 | PS50221 | |
| Domain | - | 3.83e-03 | 74 | 161 | 4 | 3.40.50.410 | |
| Domain | G_GB1_RHD3_dom | 3.86e-03 | 11 | 161 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 3.86e-03 | 11 | 161 | 2 | IPR015894 | |
| Domain | Guanylate-bd_C | 3.86e-03 | 11 | 161 | 2 | IPR003191 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 6.98e-09 | 9 | 128 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.52e-08 | 11 | 128 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 1.68e-06 | 23 | 128 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 4.74e-06 | 28 | 128 | 5 | M27837 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 3.96e-05 | 8 | 128 | 3 | MM14717 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.05e-04 | 52 | 128 | 5 | M14171 | |
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.39e-11 | 6 | 166 | 5 | 2788608 | |
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.39e-11 | 6 | 166 | 5 | 6608795 | |
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 7946325 | ||
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 2081604 | ||
| Pubmed | AMY1B AMY1C AMY2A AMY2B IFI44 CUBN TF HMCN1 GZMA SCN7A ADGRL2 PRLR | 2.27e-11 | 162 | 166 | 12 | 23012479 | |
| Pubmed | 1.29e-10 | 8 | 166 | 5 | 12414807 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 1.29e-10 | 8 | 166 | 5 | 6200103 | |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 5.01e-10 | 4 | 166 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 5.01e-10 | 4 | 166 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 5.01e-10 | 4 | 166 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 5.01e-10 | 4 | 166 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 5.01e-10 | 4 | 166 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 5.01e-10 | 4 | 166 | 4 | 94264 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 3872721 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 5.01e-10 | 4 | 166 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 5.01e-10 | 4 | 166 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 5.01e-10 | 4 | 166 | 4 | 2987507 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6091898 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 5.01e-10 | 4 | 166 | 4 | 6162108 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 16152770 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 2423416 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 5.01e-10 | 4 | 166 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 5.01e-10 | 4 | 166 | 4 | 2989529 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 5.01e-10 | 4 | 166 | 4 | 1141004 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 5.01e-10 | 4 | 166 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 5.01e-10 | 4 | 166 | 4 | 6207174 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 5.01e-10 | 4 | 166 | 4 | 2332419 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CAB39 COL6A1 FLNB AMY1A AMY1B AMY1C AMY2A AMY2B LAMA3 LAMA5 ACTN4 ACTN1 CUBN ARL15 MDH2 DYSF TF TGM2 CILP2 IGF2R HMCN1 PLG ALDH9A1 | 1.84e-09 | 1070 | 166 | 23 | 23533145 |
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 6529441 | ||
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 2.49e-09 | 5 | 166 | 4 | 34276419 | |
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 2.49e-09 | 5 | 166 | 4 | 8661735 | |
| Pubmed | 2.91e-09 | 13 | 166 | 5 | 489953 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | NPC1 CAB39 COL6A1 FLNB VWF STXBP4 KIF12 LAMA5 ACTN1 CUBN ARL15 MDH2 DYSF TF TIAM2 ACSL4 TGM2 IGF2R PKD1 ALDH3B1 ALDH9A1 MVP | 3.76e-09 | 1016 | 166 | 22 | 19056867 |
| Pubmed | 4.51e-09 | 14 | 166 | 5 | 2902233 | ||
| Pubmed | Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. | 7.45e-09 | 6 | 166 | 4 | 1716634 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 2002257 | ||
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 7.45e-09 | 6 | 166 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 7.45e-09 | 6 | 166 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 7.45e-09 | 6 | 166 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 7.45e-09 | 6 | 166 | 4 | 7859283 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 7.45e-09 | 6 | 166 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.73e-08 | 7 | 166 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.73e-08 | 7 | 166 | 4 | 2451911 | |
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 7949740 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 6160178 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 8604219 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 8666240 | ||
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 2040456 | ||
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 3038891 | ||
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 3.45e-08 | 8 | 166 | 4 | 7523515 | |
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 2824476 | ||
| Pubmed | 6.19e-08 | 9 | 166 | 4 | 93520 | ||
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 9121556 | ||
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 2897103 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.07e-07 | 3 | 166 | 3 | 2413838 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.07e-07 | 3 | 166 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.07e-07 | 3 | 166 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.07e-07 | 3 | 166 | 3 | 2436036 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.07e-07 | 3 | 166 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.07e-07 | 3 | 166 | 3 | 17223109 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 15299664 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 8413315 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 1.07e-07 | 3 | 166 | 3 | 7678001 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 6098446 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 30982860 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 1699843 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 12527308 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 2414282 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 28659346 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 25588701 | ||
| Pubmed | 1.21e-07 | 167 | 166 | 9 | 22159717 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 23449223 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 7608209 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 1617215 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 2903254 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 2565740 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.61e-07 | 11 | 166 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.61e-07 | 11 | 166 | 4 | 8589528 | |
| Pubmed | 2.40e-07 | 12 | 166 | 4 | 8144363 | ||
| Pubmed | 3.02e-07 | 30 | 166 | 5 | 6375655 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 3.46e-07 | 13 | 166 | 4 | 7829080 | |
| Pubmed | Expression profile of MODY3/HNF-1alpha protein in the developing mouse pancreas. | 3.46e-07 | 13 | 166 | 4 | 12189445 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 2458567 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 20939500 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 4.26e-07 | 4 | 166 | 3 | 8543783 | |
| Cytoband | 1p21 | 2.34e-08 | 24 | 166 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 4.59e-05 | 107 | 166 | 5 | chr1p21 | |
| Cytoband | 3p14.3 | 1.75e-04 | 30 | 166 | 3 | 3p14.3 | |
| Cytoband | 18q11.2 | 6.70e-04 | 47 | 166 | 3 | 18q11.2 | |
| GeneFamily | Tubulin tyrosine ligase family | 7.80e-05 | 14 | 111 | 3 | 779 | |
| GeneFamily | Aldehyde dehydrogenases | 2.03e-04 | 19 | 111 | 3 | 398 | |
| GeneFamily | Actinins | 2.22e-04 | 4 | 111 | 2 | 1112 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.76e-04 | 161 | 111 | 6 | 593 | |
| GeneFamily | Proteases, serine | 6.07e-04 | 63 | 111 | 4 | 738 | |
| GeneFamily | Laminin subunits | 2.37e-03 | 12 | 111 | 2 | 626 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.24e-03 | 14 | 111 | 2 | 1095 | |
| GeneFamily | Sulfotransferases, cytosolic | 3.24e-03 | 14 | 111 | 2 | 762 | |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 1.18e-08 | 131 | 166 | 10 | M40316 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RC3H2 AMY1B AMY1C AMY2A AMY2B THSD7A ASB15 IDS DMXL1 ACSL4 RNF103 SCN7A TBC1D12 ARHGAP28 ADGRF5 PRKG1 PPIP5K2 PARP12 PLCE1 EPHB1 | 9.55e-07 | 888 | 166 | 20 | MM1018 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | FLNB VWF DOCK9 IFI44 LAMA5 ACTN4 SLC7A8 TGM2 HMCN1 ADGRF5 ADGRL2 VWA2 PARP12 | 4.97e-06 | 440 | 166 | 13 | M39039 |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_DC_UP | 5.52e-06 | 200 | 166 | 9 | M5195 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 9.41e-06 | 116 | 166 | 7 | MM1240 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 2.47e-05 | 185 | 166 | 8 | MM1072 | |
| Coexpression | XIE_ST_HSC_S1PR3_OE_UP | 2.88e-05 | 189 | 166 | 8 | M41755 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RC3H2 AMY2A THSD7A ASB15 IDS DMXL1 ACSL4 RNF103 SCN7A TBC1D12 ARHGAP28 ADGRF5 PRKG1 PPIP5K2 PARP12 PLCE1 EPHB1 | 3.19e-05 | 854 | 166 | 17 | M1533 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | EPHB2 PRR5L THSD7A ZNF521 SLC43A3 SPOCK3 SCN3A NAV3 PRKG1 MVP EPHB1 | 3.43e-05 | 382 | 166 | 11 | M45756 |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 3.95e-05 | 60 | 166 | 5 | MM654 | |
| Coexpression | BERGER_MBD2_TARGETS | 3.97e-05 | 11 | 166 | 3 | MM905 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPP2 COL6A1 WIPI1 ANK2 DOCK9 CYP51A1 LAMA5 ACTN4 DMXL1 SLC7A8 MGAT2 IGF2R PIGA SULT1A3 PPIP5K2 PARP12 | 4.49e-05 | 790 | 166 | 16 | M12490 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | PRR5L DOCK9 SLC43A3 TECRL ARL15 IDS SULT1A4 SULT1A3 GZMA SCN7A ADGRF5 SLC7A10 | 7.35e-05 | 491 | 166 | 12 | MM455 |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 9.95e-05 | 289 | 166 | 9 | MM1238 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | AMY1A PRR5L THSD7A ANK2 CYP51A1 ZNF521 IDS TIAM2 ACSL3 SCML2 ZIK1 HMCN1 SPOCK3 TLL1 TTLL4 GLRB SCN3A ARHGAP28 TRPM1 VWA2 | 9.46e-06 | 850 | 164 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | CACNA1D THSD7A HIF3A ARL15 HMCN1 TLL1 GLRB SCN3A ARHGAP28 TVP23A | 2.01e-05 | 243 | 164 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | VWF MYOM1 STXBP4 IFI44 ZNF521 SLC43A3 SLC7A8 ACSL3 TGM2 PRKG1 ADGRL2 PRDM16 IL36G | 2.55e-05 | 422 | 164 | 13 | GSM399442_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CACNA1D WIPI1 PRR5L THSD7A ZNF521 LAMA3 HIF3A IDS TF TIAM2 EPM2AIP1 HMCN1 GLRB SCN3A NAV3 TRPM1 PLG ATL2 | 2.92e-05 | 769 | 164 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | AMY1A PRR5L CYP51A1 ZNF521 IDS SCML2 ZIK1 MGAT2 SPOCK3 TLL1 GLRB SCN3A TRPM1 | 3.02e-05 | 429 | 164 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | PDE3A THSD7A IFI44 ACTN4 SLC43A3 ASB15 IDS DYSF TDRD7 SLC7A8 ACSL4 GZMA SCN7A CLEC2D ARHGAP28 ADGRF5 PRKG1 PARP12 PLCE1 | 5.02e-05 | 878 | 164 | 19 | gudmap_kidney_adult_RenCorpuscGlomer_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | COL6A1 PDE3A WIPI1 THSD7A LAMA5 CPZ SLC43A3 TF TGM2 HMCN1 FCGRT SCN7A ADGRL2 | 7.03e-05 | 466 | 164 | 13 | GSM777050_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | AMY1A PRR5L THSD7A CYP51A1 ZNF521 IDS TIAM2 EPM2AIP1 ACSL3 SCML2 ZIK1 MGAT2 HMCN1 SPOCK3 TLL1 GLRB SCN3A TRPM1 | 8.54e-05 | 836 | 164 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_2500_k-means-cluster#3 | 9.09e-05 | 183 | 164 | 8 | geo_heart_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | EPHB2 CACNA1D PDE3A WIPI1 THSD7A LAMA3 HIF3A ARL15 IDS ST14 HMCN1 TLL1 GLRB SCN3A ARHGAP28 ATL2 TVP23A | 1.73e-04 | 806 | 164 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | VIPR1 COL6A1 VWF ATG7 MAMLD1 IFI44 IRAK2 DUSP15 PSMD13 FCGRT DNAJC11 GLRB ADAMTS17 PCDH15 NAV3 TRPM1 PPIP5K2 PRDM16 PARP12 | 2.05e-04 | 978 | 164 | 19 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | COL6A1 PDE3A AMY1A WIPI1 THSD7A SLC43A3 TF TGM2 FCGRT SCN7A PCDH15 ADGRL2 | 2.25e-04 | 455 | 164 | 12 | GSM777055_500 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | VWF DOCK9 IFI44 ZNF521 LAMA3 LAMA5 SLC43A3 DYSF TGM2 TLL1 ADGRF5 ADGRL2 | 2.30e-04 | 456 | 164 | 12 | GSM777032_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | VWF DOCK9 IFI44 ZNF521 LAMA3 LAMA5 SLC43A3 DYSF TGM2 TLL1 ADGRF5 ADGRL2 | 2.44e-04 | 459 | 164 | 12 | GSM777037_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | FLNB PRR5L THSD7A DOCK9 ZNF521 ACTN4 AIDA SLC43A3 DYSF TF TDRD7 HMCN1 CLEC2D NAV3 ARHGAP28 ADGRF5 ADGRL2 | 2.48e-04 | 831 | 164 | 17 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | CAB39 PDE3A PDE3B THSD7A LAMA5 ACTN4 ASB15 IDS ACSL4 ZNF277 ARHGAP28 PRKG1 PPIP5K2 MVP PARP12 PLCE1 EPHB1 | 2.73e-04 | 838 | 164 | 17 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | COL6A1 PDE3A MYOM1 IRAK2 CPZ ACTN1 HIF3A IDS SMYD4 TGM2 IGF2R FCGRT SCN7A PRKG1 FAM118A ATL2 | 2.80e-04 | 761 | 164 | 16 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | VWF THSD7A ATG7 DOCK9 MAMLD1 IRAK2 CUBN DYSF IHO1 TDRD7 TGM2 FCGRT TLL1 GLRB NAV3 ADGRF5 MVP PARP12 | 3.43e-04 | 936 | 164 | 18 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | VWF MYOM1 STXBP4 IFI44 ZNF521 SLC7A8 TGM2 PRKG1 ADGRL2 PRDM16 IL36G | 3.49e-04 | 409 | 164 | 11 | GSM476663_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | AMY1A CYP51A1 IDS TIAM2 ACSL3 SCML2 ZIK1 HMCN1 SPOCK3 TTLL4 GLRB VWA2 | 3.52e-04 | 478 | 164 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HNF1A VWF CAMK2B PTDSS2 CCDC38 HMCN1 TTLL11 SCN7A ADGRF5 POLN TVP23A PRLR | 3.17e-12 | 176 | 166 | 12 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HNF1A VWF CAMK2B PTDSS2 CCDC38 HMCN1 TTLL11 SCN7A ADGRF5 POLN TVP23A PRLR | 3.17e-12 | 176 | 166 | 12 | 88ca2f83d8301633232735f39b0683efe49d0b86 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FLNB PDE3A PDE3B VWF THSD7A DOCK9 MAMLD1 ARL15 CCDC38 TIAM2 HMCN1 PRDM16 | 8.33e-12 | 191 | 166 | 12 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 FLNB ACTN4 ACTN1 ACSL4 HMCN1 SCN3A SCN7A ADAMTS17 ADGRL2 PRDM16 | 1.44e-10 | 189 | 166 | 11 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDE3A VWF THSD7A DOCK9 ZNF521 ACTN1 TGM2 HMCN1 TLL1 PCDH15 PRKG1 | 1.44e-10 | 189 | 166 | 11 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CACNA1D COL6A1 ANK2 HIF3A HMCN1 SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 PRKG1 | 1.61e-10 | 191 | 166 | 11 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | FLNB VWF THSD7A DOCK9 ZNF521 ACTN1 TGM2 HMCN1 TLL1 PCDH15 ATL2 | 1.70e-10 | 192 | 166 | 11 | c0c34785a7bdf461722029b322e9184e3d9b3c26 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CACNA1D COL6A1 ANK2 HIF3A HMCN1 SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 PRKG1 | 1.70e-10 | 192 | 166 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1D COL6A1 MAMLD1 HIF3A HMCN1 SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 PRKG1 | 1.80e-10 | 193 | 166 | 11 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CACNA1D COL6A1 ANK2 HIF3A HMCN1 SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 PRKG1 | 2.12e-10 | 196 | 166 | 11 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | CACNA1D COL6A1 PDE3A ANK2 ZNF521 HIF3A HMCN1 SCN7A NAV3 ARHGAP28 PRKG1 | 2.36e-10 | 198 | 166 | 11 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | FLNB ACTN4 ACTN1 ACSL4 HMCN1 SCN3A SCN7A ADAMTS17 ADGRL2 PRDM16 | 2.29e-09 | 187 | 166 | 10 | f124d2c699b717b7c02a1a70493f515b83dc2f4c |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.29e-09 | 187 | 166 | 10 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.41e-09 | 188 | 166 | 10 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-09 | 191 | 166 | 10 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-09 | 191 | 166 | 10 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-09 | 192 | 166 | 10 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-09 | 193 | 166 | 10 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-09 | 193 | 166 | 10 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1D COL6A1 MAMLD1 HIF3A SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 PRKG1 | 3.26e-09 | 194 | 166 | 10 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | CACNA1D HIF3A TGM2 HMCN1 SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 PRKG1 | 3.43e-09 | 195 | 166 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1D COL6A1 PDE3A HIF3A HMCN1 SCN7A PCDH15 NAV3 ARHGAP28 PRKG1 | 3.60e-09 | 196 | 166 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL6A1 PDE3A ANK2 ZNF521 HIF3A HMCN1 SCN7A NAV3 ARHGAP28 PRKG1 | 4.38e-09 | 200 | 166 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1D COL6A1 HIF3A TGM2 HMCN1 SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 | 4.38e-09 | 200 | 166 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.38e-09 | 200 | 166 | 10 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1D COL6A1 PDE3A ANK2 HIF3A HMCN1 SCN7A PCDH15 NAV3 ARHGAP28 | 4.38e-09 | 200 | 166 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-09 | 156 | 166 | 9 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-08 | 186 | 166 | 9 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | CACNA1D HIF3A HMCN1 SCN7A ADAMTS17 PCDH15 NAV3 ARHGAP28 PRKG1 | 3.68e-08 | 187 | 166 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CACNA1D STXBP4 ACSL4 HMCN1 SCN3A SCN7A ADAMTS17 ADGRL2 PRDM16 | 4.04e-08 | 189 | 166 | 9 | 975c0f079903ae36b0ffa54e86294d42ec7697de |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.04e-08 | 189 | 166 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.04e-08 | 189 | 166 | 9 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CACNA1D STXBP4 ACSL4 HMCN1 SCN3A SCN7A ADAMTS17 ADGRL2 PRDM16 | 4.04e-08 | 189 | 166 | 9 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.22e-08 | 190 | 166 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.22e-08 | 190 | 166 | 9 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.22e-08 | 190 | 166 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.62e-08 | 192 | 166 | 9 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.62e-08 | 192 | 166 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-08 | 193 | 166 | 9 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 4.83e-08 | 193 | 166 | 9 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1D COL6A1 MAMLD1 HIF3A HMCN1 SCN7A PCDH15 ARHGAP28 PRKG1 | 4.83e-08 | 193 | 166 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.05e-08 | 194 | 166 | 9 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.05e-08 | 194 | 166 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.05e-08 | 194 | 166 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.28e-08 | 195 | 166 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.28e-08 | 195 | 166 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-08 | 196 | 166 | 9 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.52e-08 | 196 | 166 | 9 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.02e-08 | 198 | 166 | 9 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 6.28e-08 | 199 | 166 | 9 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.28e-08 | 199 | 166 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.56e-08 | 200 | 166 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.56e-08 | 200 | 166 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 200 | 166 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 200 | 166 | 9 | 2d962c9d63e9e5f1a06870e383609672e7b1738c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 200 | 166 | 9 | 2989325b0e78ab42f362cfb59e34a4fce7f8e869 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.56e-08 | 200 | 166 | 9 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 200 | 166 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 200 | 166 | 9 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.56e-08 | 200 | 166 | 9 | d9d0ffa18e5b4647966e19ad9830cbba6120677e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 200 | 166 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.56e-08 | 200 | 166 | 9 | e9d5ba140cabae11c437012d519b85f5412dcc94 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.56e-08 | 200 | 166 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.79e-07 | 172 | 166 | 8 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.48e-07 | 177 | 166 | 8 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-07 | 177 | 166 | 8 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-07 | 179 | 166 | 8 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-07 | 179 | 166 | 8 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.79e-07 | 179 | 166 | 8 | 040a7e916baaf81f44339dc721ab2afcd2c22388 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.12e-07 | 181 | 166 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-07 | 182 | 166 | 8 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.48e-07 | 183 | 166 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.67e-07 | 184 | 166 | 8 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.67e-07 | 184 | 166 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.86e-07 | 185 | 166 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.86e-07 | 185 | 166 | 8 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.86e-07 | 185 | 166 | 8 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 5.07e-07 | 186 | 166 | 8 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.07e-07 | 186 | 166 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.28e-07 | 187 | 166 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 5.28e-07 | 187 | 166 | 8 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-07 | 187 | 166 | 8 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.28e-07 | 187 | 166 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.49e-07 | 188 | 166 | 8 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.49e-07 | 188 | 166 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-07 | 188 | 166 | 8 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.49e-07 | 188 | 166 | 8 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-07 | 188 | 166 | 8 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.72e-07 | 189 | 166 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 5.72e-07 | 189 | 166 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 5.72e-07 | 189 | 166 | 8 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-07 | 190 | 166 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.95e-07 | 190 | 166 | 8 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.95e-07 | 190 | 166 | 8 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.95e-07 | 190 | 166 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.95e-07 | 190 | 166 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.95e-07 | 190 | 166 | 8 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-07 | 190 | 166 | 8 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.95e-07 | 190 | 166 | 8 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.95e-07 | 190 | 166 | 8 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| Computational | Oxidoreductases. | 2.56e-04 | 14 | 99 | 3 | MODULE_464 | |
| Computational | Genes in the cancer module 194. | 3.18e-04 | 15 | 99 | 3 | MODULE_194 | |
| Computational | Genes in the cancer module 465. | 3.89e-04 | 16 | 99 | 3 | MODULE_465 | |
| Computational | Genes in the cancer module 470. | 3.89e-04 | 16 | 99 | 3 | MODULE_470 | |
| Drug | R 623 | 1.16e-10 | 6 | 166 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.16e-10 | 6 | 166 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 1.16e-10 | 6 | 166 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.16e-10 | 6 | 166 | 5 | CID000127364 | |
| Drug | CNP-G3 | 1.16e-10 | 6 | 166 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 4.03e-10 | 7 | 166 | 5 | CID000174858 | |
| Drug | BG5P | 4.03e-10 | 7 | 166 | 5 | CID003082752 | |
| Drug | Bay e 4609 | 1.03e-09 | 16 | 166 | 6 | CID003085308 | |
| Drug | desethylaprophen | 1.07e-09 | 8 | 166 | 5 | CID000163919 | |
| Drug | azintamide | 1.07e-09 | 8 | 166 | 5 | CID000071105 | |
| Drug | GU-3 | 2.39e-09 | 9 | 166 | 5 | CID000448687 | |
| Drug | alpha-maltosyl fluoride | 2.39e-09 | 9 | 166 | 5 | CID000194237 | |
| Drug | trestatin A | 2.39e-09 | 9 | 166 | 5 | CID003054994 | |
| Drug | Atonik | 2.39e-09 | 9 | 166 | 5 | CID000069471 | |
| Drug | H 187 | 2.39e-09 | 9 | 166 | 5 | CID000001742 | |
| Drug | N-PMT | 2.73e-09 | 4 | 166 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 2.73e-09 | 4 | 166 | 4 | CID003482066 | |
| Drug | SAIB-SG | 2.73e-09 | 4 | 166 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 2.73e-09 | 4 | 166 | 4 | CID013573844 | |
| Drug | Dembrexine | 2.73e-09 | 4 | 166 | 4 | CID000072009 | |
| Drug | g lw | 2.73e-09 | 4 | 166 | 4 | CID000444139 | |
| Drug | beta-santalene | 2.73e-09 | 4 | 166 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 4.75e-09 | 10 | 166 | 5 | CID000485275 | |
| Drug | Glc)4 | 4.75e-09 | 10 | 166 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 4.75e-09 | 10 | 166 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 4.75e-09 | 10 | 166 | 5 | CID000118008 | |
| Drug | validamycin D | 8.65e-09 | 11 | 166 | 5 | CID000166726 | |
| Drug | FG5P | 8.65e-09 | 11 | 166 | 5 | CID000127486 | |
| Drug | CNP-G5 | 8.65e-09 | 11 | 166 | 5 | CID000127309 | |
| Drug | HgI2 | 8.65e-09 | 11 | 166 | 5 | CID000024485 | |
| Drug | 2C KM | 8.65e-09 | 11 | 166 | 5 | CID009549196 | |
| Drug | taselin | 1.25e-08 | 23 | 166 | 6 | CID000023846 | |
| Drug | Deposiston | 1.35e-08 | 5 | 166 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.35e-08 | 5 | 166 | 4 | CID010358258 | |
| Drug | lunularic acid | 1.35e-08 | 5 | 166 | 4 | CID000161413 | |
| Drug | himachalene | 1.35e-08 | 5 | 166 | 4 | CID000015095 | |
| Drug | actinidine | 1.35e-08 | 5 | 166 | 4 | CID000068231 | |
| Drug | 2TAA | 1.35e-08 | 5 | 166 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 1.35e-08 | 5 | 166 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.35e-08 | 5 | 166 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 1.35e-08 | 5 | 166 | 4 | CID000155287 | |
| Drug | azaprophen | 1.47e-08 | 12 | 166 | 5 | CID000129486 | |
| Drug | Avenin | 1.47e-08 | 12 | 166 | 5 | CID000095924 | |
| Drug | methyl 1'-epiacarviosin | 2.38e-08 | 13 | 166 | 5 | CID000197426 | |
| Drug | isoacarbose | 2.38e-08 | 13 | 166 | 5 | CID000449165 | |
| Drug | 8a-c | 2.38e-08 | 13 | 166 | 5 | CID000066085 | |
| Drug | Cyclodextrins | 3.68e-08 | 14 | 166 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 3.68e-08 | 14 | 166 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 3.68e-08 | 14 | 166 | 5 | CID000007488 | |
| Drug | 2-amino-6-picoline | 4.04e-08 | 6 | 166 | 4 | CID000015765 | |
| Drug | phenol blue | 4.04e-08 | 6 | 166 | 4 | CID000075078 | |
| Drug | Gu-4 | 4.04e-08 | 6 | 166 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 4.04e-08 | 6 | 166 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 4.04e-08 | 6 | 166 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 4.04e-08 | 6 | 166 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 4.04e-08 | 6 | 166 | 4 | CID006857368 | |
| Drug | vermella | 4.04e-08 | 6 | 166 | 4 | CID000203726 | |
| Drug | hymenin | 4.04e-08 | 6 | 166 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 4.04e-08 | 6 | 166 | 4 | CID000011615 | |
| Drug | 4-nitrophenylmaltoheptaoside | 5.49e-08 | 15 | 166 | 5 | CID000173254 | |
| Drug | DABITC | 5.49e-08 | 15 | 166 | 5 | CID000082084 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 7.05e-08 | 30 | 166 | 6 | CID005373003 | |
| Drug | gamma-cyclodextrin | 7.94e-08 | 16 | 166 | 5 | CID000086575 | |
| Drug | methyl blue | 9.38e-08 | 7 | 166 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 9.38e-08 | 7 | 166 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 9.38e-08 | 7 | 166 | 4 | CID000071762 | |
| Drug | Paramax | 9.38e-08 | 7 | 166 | 4 | CID000156411 | |
| Drug | amino-methyl | 9.38e-08 | 7 | 166 | 4 | CID000142005 | |
| Drug | trimitan | 1.54e-07 | 18 | 166 | 5 | CID000005561 | |
| Drug | aprophen | 1.54e-07 | 18 | 166 | 5 | CID000071128 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.67e-07 | 83 | 166 | 8 | CID011968896 | |
| Drug | boric acid gel | 1.86e-07 | 8 | 166 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.86e-07 | 8 | 166 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 1.86e-07 | 8 | 166 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.86e-07 | 8 | 166 | 4 | CID000146692 | |
| Drug | acrinor | 1.86e-07 | 8 | 166 | 4 | CID005489637 | |
| Drug | NSC300622 | 1.86e-07 | 8 | 166 | 4 | CID000028426 | |
| Drug | theodrenaline | 1.86e-07 | 8 | 166 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.86e-07 | 8 | 166 | 4 | CID000073372 | |
| Drug | GSAD | 3.34e-07 | 9 | 166 | 4 | CID009909127 | |
| Drug | zingiberene | 3.34e-07 | 9 | 166 | 4 | CID000092776 | |
| Drug | mercuric nitrate | 3.34e-07 | 9 | 166 | 4 | CID000024864 | |
| Drug | AC1L3XPY | 3.59e-07 | 21 | 166 | 5 | CID000124005 | |
| Drug | potassium thiocyanate solution | 3.59e-07 | 21 | 166 | 5 | CID010931372 | |
| Drug | AC1N3UXZ | 3.81e-07 | 3 | 166 | 3 | CID004118625 | |
| Drug | maltosaccharide | 4.62e-07 | 22 | 166 | 5 | CID005461034 | |
| Drug | I ZE | 5.53e-07 | 10 | 166 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 5.53e-07 | 10 | 166 | 4 | CID000012135 | |
| Drug | CG-120 | 5.53e-07 | 10 | 166 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 5.53e-07 | 10 | 166 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 5.53e-07 | 10 | 166 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 5.53e-07 | 10 | 166 | 4 | CID000440202 | |
| Drug | Panose B | 7.37e-07 | 24 | 166 | 5 | CID000439297 | |
| Drug | Tempamine | 8.64e-07 | 11 | 166 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 8.64e-07 | 11 | 166 | 4 | CID000164608 | |
| Drug | AMO-1618 | 8.64e-07 | 11 | 166 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 8.64e-07 | 11 | 166 | 4 | CID000430710 | |
| Drug | CID439354 | 9.16e-07 | 25 | 166 | 5 | CID000439354 | |
| Drug | chloroisocyanuric acid | 1.29e-06 | 12 | 166 | 4 | CID000017921 | |
| Drug | glyciphosphoramide | 1.29e-06 | 12 | 166 | 4 | CID000197092 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 1.18e-08 | 6 | 158 | 4 | DOID:14501 (implicated_via_orthology) | |
| Disease | alpha-amylase 1 measurement | 9.77e-08 | 9 | 158 | 4 | EFO_0801371 | |
| Disease | non-syndromic X-linked intellectual disability 63 (implicated_via_orthology) | 2.85e-05 | 2 | 158 | 2 | DOID:0112050 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 8.30e-05 | 43 | 158 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia 3A (implicated_via_orthology) | 8.52e-05 | 3 | 158 | 2 | DOID:0110791 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | FLNB PDE3A DOCK9 ACTN4 DNAAF9 ARL15 DYSF ATP13A2 DNAH7 TLL1 PKD1 NAV3 ARHGAP28 PRKG1 FAM118A ADGRL2 PRLR PLCE1 EPHB1 | 1.12e-04 | 1345 | 158 | 19 | EFO_0010736 |
| Disease | osteonecrosis (is_marker_for) | 1.70e-04 | 4 | 158 | 2 | DOID:10159 (is_marker_for) | |
| Disease | pulse pressure measurement | NPC1 CACNA1D COL6A1 FLNB RC3H2 PDE3A ANK2 ATG7 CYP51A1 LAMA5 ACTN4 ARL15 DYSF CILP2 PKD1 TBC1D12 FAM118A PRDM16 PLCE1 | 1.74e-04 | 1392 | 158 | 19 | EFO_0005763 |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 2.82e-04 | 5 | 158 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 3.58e-04 | 26 | 158 | 3 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | serum albumin measurement | HNF1A WIPI1 DOK7 MAMLD1 ARL15 DYSF TF PHKG2 CILP2 LLGL1 FCGRT | 3.65e-04 | 592 | 158 | 11 | EFO_0004535 |
| Disease | coronary artery disease | NPC1 HNF1A WIPI1 THSD7A DOCK9 DOK7 ARL15 DMXL1 PTK7 IGF2R PRKG1 PLG ADGRL2 PRDM16 PARP12 PLCE1 | 7.04e-04 | 1194 | 158 | 16 | EFO_0001645 |
| Disease | gestational diabetes (is_implicated_in) | 7.81e-04 | 8 | 158 | 2 | DOID:11714 (is_implicated_in) | |
| Disease | total iron binding capacity | 8.30e-04 | 78 | 158 | 4 | EFO_0006334 | |
| Disease | cerebrospinal fluid clusterin measurement | 8.69e-04 | 35 | 158 | 3 | EFO_0007657 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 8.75e-04 | 137 | 158 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | Liver Cirrhosis, Experimental | VIPR1 COL6A1 VWF AIDA ACTN1 DYSF ST14 IGF2R GZMA PLG MVP PRLR | 9.82e-04 | 774 | 158 | 12 | C0023893 |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 1.00e-03 | 9 | 158 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | glucose measurement | 1.06e-03 | 380 | 158 | 8 | EFO_0004468 | |
| Disease | response to anticonvulsant | 1.14e-03 | 85 | 158 | 4 | GO_0036277 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.14e-03 | 85 | 158 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | FLNB HNF1A PDE3A THSD7A ATG7 OBSCN MUC19 CUBN CILP2 FCGRT FAM118A TVP23A PLCE1 | 1.20e-03 | 904 | 158 | 13 | EFO_0004736 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.25e-03 | 10 | 158 | 2 | C1631597 | |
| Disease | level of Phosphatidylcholine (18:0_22:5) in blood serum | 1.25e-03 | 10 | 158 | 2 | OBA_2045096 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.52e-03 | 11 | 158 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.66e-03 | 94 | 158 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | Alcohol Use Disorder | 1.70e-03 | 44 | 158 | 3 | C0001956 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.82e-03 | 12 | 158 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.89e-03 | 163 | 158 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | 1.95e-03 | 517 | 158 | 9 | EFO_0010554 | |
| Disease | Malignant neoplasm of breast | FLNB XIRP1 VWF ANK2 STXBP4 OBSCN CUBN DYSF TGM2 LLGL1 ZNF277 TLL1 SCP2 LZTS2 | 1.97e-03 | 1074 | 158 | 14 | C0006142 |
| Disease | aortic measurement | 2.39e-03 | 251 | 158 | 6 | EFO_0020865 | |
| Disease | atrial fibrillation (is_implicated_in) | 2.49e-03 | 14 | 158 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | platelet component distribution width | NPC1 VWF DOCK9 MAMLD1 LAMA5 SLC43A3 ACTN1 CUBN ACSL3 ADGRF5 PRDM16 | 2.58e-03 | 755 | 158 | 11 | EFO_0007984 |
| Disease | Influenza | 2.75e-03 | 52 | 158 | 3 | C0021400 | |
| Disease | Early Pregnancy Loss | 2.85e-03 | 109 | 158 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 2.85e-03 | 109 | 158 | 4 | C0000786 | |
| Disease | Miscarriage | 2.85e-03 | 109 | 158 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 2.85e-03 | 109 | 158 | 4 | C0000822 | |
| Disease | Proteinuria | 2.86e-03 | 15 | 158 | 2 | HP_0000093 | |
| Disease | serum selenium measurement | 2.90e-03 | 53 | 158 | 3 | EFO_0005266 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 3.25e-03 | 16 | 158 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | body weight | NPC1 HNF1A STXBP4 ZNF521 HIF3A ACSL3 PTPN9 DNAH12 SPOCK3 TLL1 PKD1 ADAMTS17 PCDH15 POLN EPHB1 | 3.27e-03 | 1261 | 158 | 15 | EFO_0004338 |
| Disease | serum non-albumin protein measurement | 3.42e-03 | 361 | 158 | 7 | EFO_0004568 | |
| Disease | Abnormality of refraction | EPHB2 CACNA1D COL6A1 PDE3A THSD7A MAMLD1 CPZ TDRD7 TLL1 TRPM1 | 3.49e-03 | 673 | 158 | 10 | HP_0000539 |
| Disease | Hypertrophic Cardiomyopathy | 3.57e-03 | 57 | 158 | 3 | C0007194 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 3.68e-03 | 17 | 158 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | amino acid measurement | 3.68e-03 | 678 | 158 | 10 | EFO_0005134 | |
| Disease | insulin resistance | 3.93e-03 | 59 | 158 | 3 | EFO_0002614 | |
| Disease | serum urea measurement | 4.08e-03 | 195 | 158 | 5 | EFO_0009795 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 4.12e-03 | 18 | 158 | 2 | OBA_2045079 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 4.59e-03 | 19 | 158 | 2 | OBA_2045199 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.05e-03 | 128 | 158 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.05e-03 | 128 | 158 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.05e-03 | 128 | 158 | 4 | C1266044 | |
| Disease | esterified cholesterol measurement | 5.05e-03 | 128 | 158 | 4 | EFO_0008589 | |
| Disease | Papillary Renal Cell Carcinoma | 5.05e-03 | 128 | 158 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.05e-03 | 128 | 158 | 4 | C0007134 | |
| Disease | Deaf Mutism | 5.08e-03 | 20 | 158 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 5.08e-03 | 20 | 158 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 5.08e-03 | 20 | 158 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 5.08e-03 | 20 | 158 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 5.08e-03 | 20 | 158 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 5.08e-03 | 20 | 158 | 2 | C0011052 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAGEQLEPGLCYCPL | 76 | O60347 | |
| GQCERIPGLGPKDTY | 301 | O60488 | |
| AKVLCGGDIYVPEDP | 351 | P49189 | |
| LPCSGGALEELRGQY | 1256 | O94986 | |
| LGPEEFKACLISLGY | 766 | P12814 | |
| PEYDLVCIGLTGSGK | 31 | Q9NXU5 | |
| KYEGEPENAVLPLCF | 176 | Q8WY22 | |
| GEPLALPLDAGEYCV | 31 | Q9HBH7 | |
| LCYAELGVAIPKSGG | 91 | Q9NS82 | |
| PVTLELGGKNPCYVD | 206 | P43353 | |
| LGGKNPCYVDDNCDP | 211 | P43353 | |
| ENKCGDPRGPGVYIL | 231 | P12544 | |
| ITENYDCGTKLPGLL | 96 | Q9NUQ8 | |
| GPEEFKACLISLGYD | 786 | O43707 | |
| NAYCELLGLTPLKGP | 1816 | Q96L96 | |
| AGGGNPDCISLLLEY | 251 | Q8WXK1 | |
| NYPEEVDCVGLIKGD | 21 | Q9C0F1 | |
| LECERYLAPKGFGGV | 41 | P0DTE7 | |
| LECERYLAPKGFGGV | 41 | P0DTE8 | |
| GPPFCLKEAYGQGLR | 4056 | Q86UQ4 | |
| DGYIIPINKEGCIPE | 1431 | O95490 | |
| LKGYESPEIALNCGI | 131 | Q9Y376 | |
| IGLKDAGQCIDPYIT | 176 | Q96BJ3 | |
| LECERYLAPKGFGGV | 41 | P0DUB6 | |
| VTLELGGKNPCYVDD | 126 | P48448 | |
| LECERYLAPKGFGGV | 41 | P19961 | |
| KRCLNEIEADLGYPG | 2616 | Q9Y485 | |
| KDEPCDTVGIAYLGG | 351 | Q8TE56 | |
| YGAGKERLAACLGVP | 686 | Q7Z5Q5 | |
| GSLVECLEKAIGYPL | 541 | Q6P1R3 | |
| REKPDDPLNYFLGGC | 81 | Q86Y39 | |
| CVEDLALYLKPLSGG | 101 | Q9HBD1 | |
| LPLVELACGEKGGYK | 181 | Q8NH87 | |
| GNLEKNRYGDVPCLD | 326 | P43378 | |
| PDDYRCGKALGPVES | 186 | Q15334 | |
| LCYAELGVTIPKSGG | 91 | Q9UHI5 | |
| LEGKPIYVDCFGNLV | 1376 | Q01484 | |
| LECERYLAPKGFGGV | 41 | P04746 | |
| EVDVPIKLYCNGDGE | 231 | P54762 | |
| GNKLCALLYGDAEKP | 41 | Q05329 | |
| LPGFYDPCVGEEKNL | 511 | Q9NVH1 | |
| GLPYECAVDVGELVG | 51 | Q9H9Y4 | |
| GLLRGGYEAQEPLCP | 61 | Q9BRK4 | |
| PPYKGCIELDDLNEN | 2556 | Q16787 | |
| LKLGCINAEYPDSFG | 206 | Q10469 | |
| QKYLEKGAGRLPEDC | 456 | O43187 | |
| PGLEGYALPRKCNTD | 186 | P33992 | |
| PLCKEAGKNLLYDLG | 571 | Q8IYA8 | |
| GEPPVGGKLCFVDLA | 251 | Q96FN5 | |
| GPGKVFGELAILYNC | 161 | Q13976 | |
| AVKGYLGPEQLPDCL | 76 | P40926 | |
| EEVDVPIKLYCNGDG | 231 | P29323 | |
| YTLQGLLGCELGPDN | 111 | P55899 | |
| DLVRAYGPGLEKSGC | 646 | O75369 | |
| YGPGLEKSGCIVNNL | 651 | O75369 | |
| AAAGEAGPCLEYLLQ | 71 | Q86V87 | |
| IPGDCPNAVGKSYEV | 626 | Q7Z5P9 | |
| PEGYLLDDIGEKGKC | 756 | Q7Z5P9 | |
| YALLGELAPCGSTDK | 426 | Q02817 | |
| DDKYGCLSGNIPALE | 811 | Q14432 | |
| VGPLCNSYDAAGLLP | 996 | Q13370 | |
| YVQPLLGKGENCLAP | 186 | Q96LB8 | |
| EVPELLPCGYLVGDN | 1996 | Q8IVL0 | |
| DPDVRLPCLEQGSYG | 201 | A8MUP2 | |
| KGPLCEPEYQALLRG | 1696 | Q6ZR08 | |
| NPGYKGESCLGAKIP | 141 | A0A1B0GTW7 | |
| YLLAGEGPLDKGESC | 36 | P20823 | |
| LGIYSPCIQEKENLG | 181 | Q6W3E5 | |
| DCYGKPIEVNNGLGK | 436 | P48167 | |
| LKGTSDDDVPCPGYL | 21 | Q96N21 | |
| QDPCFAQGDGLIKLY | 46 | Q9UNM6 | |
| PTEDLYCKLVGGPVA | 76 | O15230 | |
| GEKLRELCGTPGYLA | 181 | P15735 | |
| YCVILDPVGPDGKNQ | 281 | Q14764 | |
| LPRLCCLEKGPNGYG | 11 | O14745 | |
| ELRELYVQGGGDCPE | 106 | Q96RW7 | |
| LLPEICQHYNKGDGP | 151 | Q9H0J9 | |
| PLTEQEGEAYLEKCG | 271 | Q6MZQ0 | |
| LPKDGYDLVQELCPG | 51 | O15118 | |
| PCPDIGEVYADGVLL | 7561 | Q5VST9 | |
| GQYDDDCKLARGGPP | 26 | Q96QU1 | |
| RDGPLYQDPLLGKFC | 651 | O60494 | |
| DPCGVVLDPSGYKDV | 196 | Q9NWS6 | |
| AYVKGSPELVAGLCN | 651 | Q9NQ11 | |
| CKYPEALEQGRGDPI | 61 | Q9NZH8 | |
| DGKYLPFILCDSLGL | 241 | Q8TCB0 | |
| YEFEDCLGGGKPKAL | 401 | O95352 | |
| GCYDPLEKLRGGLEA | 156 | Q66K79 | |
| EDSQPLKCIYGRPGG | 676 | Q9BZ29 | |
| PLEGYKEPCGGLEDA | 161 | P12109 | |
| YLVVEPPEGDGALCL | 26 | Q7L775 | |
| PLGGNKEQAIYCSLE | 591 | Q8NHY3 | |
| KYQICLCFGEEDPGP | 216 | Q9H1R2 | |
| CGENLPPLTYDQLKD | 351 | Q16850 | |
| LTGGIGLDNPYANLC | 3306 | Q8WXX0 | |
| VCGGDKPYIAPSDLE | 401 | Q8NHH9 | |
| AVYDIPDLLGGNGCL | 456 | Q5TEA3 | |
| CGGEKPYLSPDILEE | 371 | Q6DD88 | |
| DGGYPNKIKRPCLED | 76 | Q13495 | |
| YKVCIGDAEDDGLNP | 441 | Q502W7 | |
| PCGYEAEDQAKLFPL | 1011 | Q12840 | |
| LGCYGDKLVRSPNID | 51 | P22304 | |
| GYGGKTCELVLPVPD | 241 | Q6UY11 | |
| DICGLEPGLPYEGLV | 61 | Q18PE1 | |
| ILECRGLGYSGLPEK | 51 | O00237 | |
| YLKTSLCVLGPGDEA | 336 | O75923 | |
| NPEECRGLFILYKDG | 1051 | Q01668 | |
| LLGIPLLDSGCGEEY | 166 | P98161 | |
| IVLKYVDGDLCPDGI | 1451 | P11717 | |
| NGDFEAYAKICDPGL | 551 | Q13554 | |
| ETPIPGCDINGKYEN | 406 | Q8IYR2 | |
| NGGCGYVLKPDFLRD | 596 | Q9BRC7 | |
| PLIGRFCGYDKPEDI | 531 | O43897 | |
| LPANGGRDCTDPLYE | 806 | Q9UPZ6 | |
| EANGGCGYVLKPPVL | 1831 | Q9P212 | |
| GGEPLDACYLKALEG | 81 | Q9Y2N7 | |
| YEGLAEELKPEGLGG | 261 | Q9HAZ2 | |
| LGVPLPERDYGGNCL | 161 | Q9BVG9 | |
| CLRDIGSGGKYAEPV | 101 | Q53H47 | |
| DYFKDLCGPDAGPIG | 41 | Q8NBI5 | |
| YVLDGQKDPLLCGNG | 326 | Q9NY46 | |
| VEKPCSGGQDLLLYP | 286 | Q8NHU6 | |
| LEKNYCRNPDGDVGG | 526 | P00747 | |
| YEALGLCPEGQGATL | 316 | P22307 | |
| GDCYKDGRLKPGDQL | 56 | Q6ZWJ1 | |
| IYQGGDLEKCNRAPI | 61 | P0DMN0 | |
| IYQGGDLEKCNRAPI | 61 | P0DMM9 | |
| TPGDAGEYVCKLILD | 341 | Q8IZF2 | |
| GLASVLYPGCDTLDK | 76 | O95573 | |
| EYLIKLPEDCGQPGS | 391 | Q8IUL8 | |
| PILGAGECAYLNDKG | 156 | Q9UHP7 | |
| CQKYPDLNFIIGGEG | 251 | P37287 | |
| GPECGTKYLLNLNLE | 521 | P21980 | |
| DGGCQGDGIYLIKDP | 341 | Q8NHH1 | |
| GPYPIACGLDDKAAS | 116 | P32241 | |
| EGDNVRLGCPYVLDP | 36 | P0DPA2 | |
| KIDACKGDSGGPLVY | 381 | Q6ZWK6 | |
| YIAGKCGLVPVLAEN | 416 | P02787 | |
| PCPLGYKEENNTGEC | 2626 | P04275 | |
| CYLASLQGGELPNPK | 696 | Q8IVF5 | |
| CEKEGDLLQPPLGYQ | 121 | Q9UQR0 | |
| PYLICPATIGDVKGD | 186 | Q9UQR0 | |
| LYEIGGNIGEHCLDP | 691 | Q9P2N2 | |
| VKLDINGLPYGLCAG | 1081 | Q96K83 | |
| KPYVICQLEEGGEPF | 46 | Q96K75 | |
| ADLPGQKPYLVGECT | 116 | Q3SY52 | |
| GVPAGTCPKDYVEIN | 391 | Q9Y5Y6 | |
| KCRLQLGGLDYLDPA | 601 | P16471 | |
| DDKIPKGAGPGCYLA | 956 | P29144 | |
| VPEGLDGYQCLCPLA | 311 | Q5GFL6 | |
| KGPDGLALPNNYCDF | 261 | Q92785 | |
| KAESLIGVYPEQGDC | 1196 | Q14683 | |
| AKLNECPLDPGGYFI | 156 | Q9NW08 | |
| KSDRGGLDAPDCLPY | 441 | Q9BWV7 | |
| KKLLGQYIPLCDEDG | 331 | Q9BQ16 | |
| GLECGKSLPGVYTNV | 241 | Q7RTY5 | |
| INPPCGENLYDEEGK | 1026 | Q7Z4N2 | |
| GENLYDEEGKRLPPC | 1031 | Q7Z4N2 | |
| GVGYGDSKDCILEPL | 26 | Q9NRM2 | |
| DNPKGLYADGGGCKL | 201 | Q8N567 | |
| VKPEELNGENAYPCG | 241 | P0C7I0 | |
| CPEGYVCVKAGINPD | 316 | Q01118 | |
| AKEDCPLYNGGNIIL | 236 | Q8TCF1 | |
| LQLECGGPFLKDYIT | 106 | Q5HYJ1 | |
| CPGDFQKPGLEGLEI | 196 | A6NH52 | |
| GAKGCEEDKNLPSGY | 896 | O43314 | |
| YNLDPQDGGECVLIK | 341 | Q5MNZ9 | |
| GAGCQKSEAPPIYLQ | 331 | Q9UI38 | |
| PYLCLAAAGENPSGK | 181 | Q14679 | |
| SQLEEGKPGYLDCLT | 421 | Q13308 | |
| GPGELCLAKYVLSGT | 796 | Q702N8 | |
| IGNRCHPKLYDEGDP | 351 | Q96RE7 | |
| DGGSPILGYFIDKCE | 536 | P52179 |